<DOC>
	<DOCNO>NCT00102765</DOCNO>
	<brief_summary>This study last 62 week . You visit clinic 17 time . Certain clinic visit include physical examination , medical history review lung function test . The purpose study see one asthma drug ( fluticasone propionate/salmeterol ) well reduce number asthma exacerbation compare another drug ( fluticasone propionate alone )</brief_summary>
	<brief_title>Study Of Asthma In Patients Of African Descent</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Inclusion criterion : History asthma least 6 month . Taking lowdose inhale corticosteroid least one month prior study ( fluticasone propionate budesonide ) . Exclusion criterion : History lifethreatening asthma . Hospitalized asthma within 3 month prior study . Current respiratory tract infection . Will able attend clinic visit entire length study . Certain medical condition make study unsafe ( congestive heart failure , uncontrolled hypertension , tuberculosis certain drug allergy ) .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>asthma exacerbation</keyword>
	<keyword>asthma</keyword>
</DOC>